DSS, INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
DSS$0.45-8.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Common Stock · Preferred Stock · Additional Paid-in · Accumulated · Total DSS · Non- controlling Interest in | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Equity · Subsidiary · Total | ||||||||||
| Balance, December 31, 2022 | 6,950,858 | $139,000 | - | $ | - | $319,766,000 | $(194,343,000) | $125,562,000 | 31,119,000 | $156,681,000 |
| - · - | ||||||||||
| Issuance of common stock, net of expenses | 62,354 | 1,000 | - | - | 267,000 | - | 268,000 | - | 268,000 | |
| Acquisition of Sentinel Brokers Company, Inc. | - | - | - | - | (70,000) | - | (70,000) | - | (70,000) | |
| Fractional shares as a result of reverse stock split | 53,560 | - | - | - | - | - | - | - | - | |
| Dividend in kind - Deconsolidation of Sharing Services Global Corporation | - | - | - | - | - | (1,206,000) | (1,206,000) | (1,206,000) | ||
| Deconsolidation of Sharing Services Global Corporation | - | - | - | - | - | - | - | 5,065,000 | 5,065,000 | |
| Net loss from continuing operations | - | - | - | - | - | (60,627,000) | (60,627,000) | (16,897,000) | (77,524,000) | |
| Balance, December 31, 2023 | 7,066,772 | $140,000 | - | $ | - | $319,963,000 | $(256,176,000) | $63,927,000 | $19,287,000 | $83,214,000 |
| Balance, December 31, 2023 | 7,066,772 | $140,000 | - | $ | - | $319,963,000 | $(256,176,000) | $63,927,000 | $19,287,000 | $83,214,000 |
| Issuance of common stock, net of expenses | 1,025,746 | 20,000 | - | - | 980,000 | - | 1,000,000 | - | 1,000,000 | |
| Issuance of common stock, net of expenses - Impact BioMedical, Inc. | - | 1,000 | - | - | 2,188,000 | - | 2,189,000 | - | 2,189,000 | |
| Stock based compensation - Impact Biomedical, Inc. | - | - | 19,000 | - | 19,000 | - | 19,000 | |||
| Net loss | - | - | - | (46,896,000) | (46,896,000) | (6,810,000) | (53,706,000) | |||
| Balance, December 31, 2024 | 8,092,518 | $161,000 | - | $ | - | $323,150,000 | $(303,072,000) | $20,239,000 | $12,477,000 | $32,716,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.